Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

506 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors.
Bonner ER, Harrington R, Eze A, Bornhorst M, Kline CN, Gordish-Dressman H, Dawood A, Das B, Chen L, Pauly R, Williams PM, Karlovich C, Peach A, Howell D, Doroshow J, Kilburn L, Packer RJ, Mueller S, Nazarian J. Bonner ER, et al. Among authors: doroshow j. NPJ Precis Oncol. 2022 Sep 6;6(1):63. doi: 10.1038/s41698-022-00306-3. NPJ Precis Oncol. 2022. PMID: 36068285 Free PMC article.
A cross-study analysis of drug response prediction in cancer cell lines.
Xia F, Allen J, Balaprakash P, Brettin T, Garcia-Cardona C, Clyde A, Cohn J, Doroshow J, Duan X, Dubinkina V, Evrard Y, Fan YJ, Gans J, He S, Lu P, Maslov S, Partin A, Shukla M, Stahlberg E, Wozniak JM, Yoo H, Zaki G, Zhu Y, Stevens R. Xia F, et al. Among authors: doroshow j. Brief Bioinform. 2022 Jan 17;23(1):bbab356. doi: 10.1093/bib/bbab356. Brief Bioinform. 2022. PMID: 34524425 Free PMC article.
Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study.
Takimoto CH, Remick SC, Sharma S, Mani S, Ramanathan RK, Doroshow J, Hamilton A, Mulkerin D, Graham M, Lockwood GF, Ivy P, Egorin M, Schuler B, Greenslade D, Goetz A, Knight R, Thomas R, Monahan BP, Dahut W, Grem JL; National Cancer Institute Organ Dysfunction Working Group Study. Takimoto CH, et al. Among authors: doroshow j. J Clin Oncol. 2003 Jul 15;21(14):2664-72. doi: 10.1200/JCO.2003.11.015. J Clin Oncol. 2003. PMID: 12860942 Clinical Trial.
NCCN Practice Guidelines for Colorectal Cancer.
Benson AB 3rd, Choti MA, Cohen AM, Doroshow JH, Fuchs C, Kiel K, Martin EW Jr, McGinn C, Petrelli NJ, Posey JA, Skibber JM, Venook A, Yeatman TJ; National Comprehensive Cancer Network. Benson AB 3rd, et al. Among authors: doroshow jh. Oncology (Williston Park). 2000 Nov;14(11A):203-12. Oncology (Williston Park). 2000. PMID: 11195411
A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer.
Bennett JM, Byrne P, Desai A, White C, DeConti R, Vogel C, Krementz E, Muggia F, Doroshow J, Plotkin D, et al. Bennett JM, et al. Among authors: doroshow j. Invest New Drugs. 1985;3(2):179-85. doi: 10.1007/BF00174167. Invest New Drugs. 1985. PMID: 3894279 Clinical Trial.
506 results